FAIRFIELD, N.J., June 7, 2012 /PRNewswire/ -- Aperture Health,
Inc. (OTC APRE) is aggressively pursuing and seeking out the newly
emerging Accountable Care Organizations ("ACOs") business models
and offering the services of Triad Therapeutics, its wholly owned
subsidiary, to help with effective transitions of care to the home
setting for patients needing IV services, as well as, the intent to
provide Medication Therapy Management Services ("MTM") at home.
The ACO is an exciting new form of provider derived via a
collaborative approach between hospitals, physicians and ancillary
health providers, including but not limited to, homecare and home
IV therapy service providers. Moreover, the ACO model is
being heavily promoted by the Centers for Medicare and Medicaid
Services ("CMS") via mandating the bundling of payments as a
measure to advance care quality, and as a means to improve clinical
outcomes and contain skyrocketing healthcare costs. In the
future, ACOs will develop and implement quality metrics, implement
widespread healthcare information technology usage and aggregate
lifesaving and helpful data with the combined service providers
with the goal to present regular patient outcomes and reporting
which will effectively monitor and assess cost savings to the
healthcare system. Accordingly, APRE believes it can serve an
integral function for ACOs in achieving their primary goal,
which most notably includes creating a patient-centered transition
of care process that will result in decreased hospital readmissions
and improved patient quality of life through establishment of a
chronic disease state management program to focus on containing
some of the largest drivers of healthcare costs.
James Hennig, R.Ph, Chief
Executive Officer and Chairman of the Board of Directors commented,
"We are extremely excited to be doing business in the ever-growing
field of home health care and IV therapy. The advent of the cost
effective ACO business model in healthcare brings even more focus
on the need to provide quality transitions of patient care from
hospital to home. By combining hi-tech nursing, clinical pharmacy,
and medication management services coupled with streamlined
communication to all medical providers, we can help any ACO reach
the goal of high quality continuity of care while being a catalyst
for reducing healthcare costs."
About Aperture Health, and Triad Therapeutics
Aperture Health through its wholly owned subsidiary Triad
Therapeutics operates a fully JCAHO accredited home IV therapy
company, achieving this "gold standard" status in 2007. The company
has built a well respected reputation in its industry for its
therapy expertise and commitment to care for its patient clients.
The company services clients throughout the States of New Jersey, New
York and Connecticut,
providing opportunity for organic growth. Triad's full time
marketing and sales personnel continuously represent the company in
the core services areas, growing and maintaining the company's
referral source base. Patient referrals are made from physicians,
hospitals, insurance companies, veterinarians and hospice care
providers that have established a professional rapport with
Triad.
Safe Harbor
Certain statements in this news release are forward-looking,
including (without limitation) growing revenues and earnings,
expected results from current projects and attracting new
business. Undue reliance should not be placed on such
forward-looking statements because the matters they describe are
subject to known and unknown risks, uncertainties and other
unpredictable factors, many of which are beyond the Company's
control. The Company's actual results, performance and trends could
differ materially from those indicated or implied by such
statements as a result of various factors, including (without
limitation) the continued strengthening of Triad's selling and
marketing functions, continued customer satisfaction, contract
renewal, new product development, continued availability of capable
dedicated personnel, continued cost management, success and
availability of acquisitions, availability of financing and other
factors, as well as by factors applicable to most companies such as
general economic, competitive and other business and civil
conditions. Information regarding certain of those and other
risk factors and cautionary statements that could affect future
results, performance or trends is discussed in the Company's OTC
Disclosure Statement and unaudited management financials posted on
www.pinksheets.com . All of the Company's forward-looking
statements are expressly qualified by all such risk factors and
other cautionary statements. The information set forth herein
speaks only as of the date hereof.
SOURCE Aperture Health, Inc.